Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Stoschitzky Kurt |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2022
Kommentar
** Stoschitzky, K
Polypill Strategy in Secondary Cardiovascular Prevention
NEW ENGL J MED. 2022; 387(23): 2196-2198.
Doi: 10.1056/NEJMc2213446
Web of Science
PubMed
FullText
FullText_MUG
2021
Korrespondenz
** Stoschitzky, K
Differences between beta-blockers in the treatment of arterial hypertension.
J Hypertens. 2021; 39(2):384-385
Doi: 10.1097/HJH.0000000000002722
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Weber, T; Arbeiter, K; Ardelt, F; Auer, J; Aufricht, C; Brandt, MC; Dichtl, W; Ferrari, J; Föger, B; Henkel, M; Hohenstein-Scheibenecker, K; Horn, S; Kautzky-Willer, A; Kepplinger, E; Knoflach, M; Koppelstätter, C; Mache, C; Marschang, P; Mayer, G; Metzler, B; Oberbauer, R; Obermair, F; Obermayer-Pietsch, B; Perl, S; Pilz, S; Prischl, FC; Podczeck-Schweighofer, A; Rebhandl, E; Rohla, M; Roller-Wirnsberger, R; Saely, CH; Siostrzonek, P; Slany, J; Stoschitzky, K; Waldegger, S; Wenzel, RR; Weiss, T; Wirnsberger, G; Winhofer-Stöckl, Y; Zweiker, D; Zweiker, R; Watschinger, B; Österreichische Gesellschaft für Hypertensiologie; Österreichische Atherosklerosegesellschaft; Österreichische Diabetes Gesellschaft; Österreichische Gesellschaft für Internistische Angiologie; Österreichische Gesellschaft für Nephrologie; Österreichische Kardiologische Gesellschaft; Österreichische Gesellschaft für Neurologie; Österreichische Schlaganfall-Gesellschaft; Österr. Gesellschaft für Allgemeinmedizin; Österr. Gesellschaft für Geriatrie; Österreichische Gesellschaft für Endokrinologie und Stoffwechsel; Österreichische Gesellschaft für Innere Medizin; Österreichische Gesellschaft für Kinder- und Jugendheilkunde
[Austrian Consensus on High Blood Pressure 2019].
Wien Klin Wochenschr. 2019; 131(Suppl 6):489-590
Doi: 10.1007/s00508-019-01565-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Kommentar
** Stoschitzky, K; Stoschitzky, G; Lercher, P; Brussee, H
Oral loading of propafenone: restoring its role before restoring rhythm-authors' reply.
EUROPACE. 2017; 19(11): 1903-1904.
Doi: 10.1093/europace/euw342
Web of Science
PubMed
FullText
FullText_MUG
2016
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Stoschitzky, G; Lercher, P; Brussee, H; Lamprecht, G; Lindner, W
Propafenone shows class Ic and class II antiarrhythmic effects.
Europace. 2016; 18(4):568-571
Doi: 10.1093/europace/euv195
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Abstract (Zeitschrift)
** Stoschitzky, K; Stoschitzky, G; Pieske, B;
No evidence of nitrate tolerance with Nicorandil.
EUR HEART J. . 2012; 33: 470-470.-Congress of the European-Society-of-Cardiology (ESC); AUG 25-29, 2012; Munchen, GERMANY.
[Poster]
Web of Science
2011
Abstract (Zeitschrift)
** Stoschitzky, G; Pieske, B; Stoschitzky, K
Long-term Therapy with Nebivolol does not cause Nitrate Tolerance
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A56-A56.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA.
[Poster]
Web of Science
** Stoschitzky, G; Zweiker, R; Pieske, B; Stoschitzky, K
Is the Cross Product of systolic Blood Pressure and Heart Rate a Predictor of Morbidity and Mortality in arterial Hypertension?
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A55-A55.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA.
[Poster]
Web of Science
** Stoschitzky, G; Zweiker, R; Pieske, B; Stoschitzky, K
Variable beta-blocking Effects of Metoprolol, Bisoprolol and Carvedilol
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A55-A55.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA.
[Poster]
Web of Science
2010
Editorial
** Stoschitzky, K
Beta-Blockers in Acute Coronary Syndrome
CARDIOLOGY. 2010; 115(3): 170-171.
Doi: 10.1159/000271470
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** Stoschitzky, G; Maier, R; Hoedl, R; Stoschitzky, K; Pieske, B; Luha, O
Echocardiographic follow-up one year and two years after transcatheter aortic valve implantation.
EUR HEART J. 2010; 31: 863-864.
[Poster]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Lamprecht, G; Stoschitzky, K
Enantioselective analysis of R- and S-propafenone in plasma by HPLC applying column switching and liquid-liquid extraction
J CHROMATOGR B. 2009; 877(29): 3489-3494.
Doi: 10.1016/j.jchromb.2009.08.024
Web of Science
FullText
FullText_MUG
2008
Abstract (Zeitschrift)
** Stoschitzky, K; Stoschitzky, G; Zweiker, R
The rate pressure product - A predictor of outcome in arterial hypertension?
J HYPERTENSION. 2008; 26: S360-S360.
[Poster]
Web of Science
2007
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Stoschitzky, G; Wonisch, M; Brussee, H
Differential effects of urapidil and doxazosin on heart rate.
Eur J Clin Pharmacol. 2007; 63(3):259-262
Doi: 10.1007/s00228-006-0256-2
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Stoschitzky, K
Treatment of hyperlipidaemia and diabetes: state of the art 2007. Proceedings of the Educational Autumn Meeting on Advances in Cardiovascular Drug Therapy. November 24-25, 2007. Vienna, Austria.
Fundam Clin Pharmacol. 2007; 21 Suppl 2(19-20): 1-43.
Doi: 10.1111/j.1472-8206.2007.00528.x
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Stoschitzky, G; Lercher, P; Maier, R; Watzinger, N; Fruhwald, FM; Zweiker, R; Brussee, H; Stoschitzky, K
Long-term administration of nebivolol does not cause nitrate tolerance.
EUR J HEART FAIL. 2007; 6: 116-117.-Heart Failure 2007; JUN 9-12, 2007; Hamburg, Germany.
Doi: 10.1016/S1567-4215(07)60325-7
[Poster]
Web of Science
FullText
FullText_MUG
** Stoschitzky, G; Maier, R; Lercher, P; Brussee, H; Zweiker, R; Watzinger, N; Fruhwald, FM; Stoschitzky, K
Different beta-blocking effects of metoprolol, bisoprolol and carvedilol.
EUR J HEART FAIL. 2007; 6: 122-122.-Heart Failure 2007; JUN 9-12, 2007; Hamburg, Germany.
Doi: 10.1016/S1567-4215(07)60342-7
[Poster]
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Stoschitzky, G; Zweiker, R; Brussee, H
Is the effect of a drug on the rate pressure product its best predictor of outcome in arterial hypertension?
CARDIOVASC DRUG THERAPY. 2007; 21: S21-S21.
[Poster]
Web of Science
** Stoschitzky, K; Stoschitzky, G; Zweiker, R; Brussee, H
Does the rate pressure product predict outcome in arterial hypertension?
J HYPERTENSION. 2007; 25: S373-S373.
[Poster]
Web of Science
** Stoschitzky, K; Stoschitzky, G; Zweiker, R; Maier, R; Lercher, P; Watzinger, N; Fruhwald, FM; Brussee, H
Different beta-blockers show different effects.
CARDIOVASC DRUG THERAPY. 2007; 21: S12-S12.
[Poster]
Web of Science
2006
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Stoschitzky, G; Brussee, H; Bonelli, C; Dobnig, H
Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Cardiology. 2006; 106(4):199-206
Doi: 10.1159/000093060
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Stoschitzky, G; Brussee, H; Stoschitzky, K
Different effects of urapidil and doxazosin on heart rate
J HYPERTENSION. 24: S19-S19.
[Poster]
Web of Science
2005
Originalarbeit (Zeitschrift)
** Gemes, G; Fuchs, TJ; Wildner, G; Smolle-Jüttner, FM; Smolle, J; Stoschitzky, K; Prause, G
The acute coronary syndrome--pre-hospital diagnostic quality.
Resuscitation. 2005; 66(3):323-330
Doi: 10.1016/j.resuscitation.2005.04.006
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Stoschitzky, G; Stoschitzky, K; Wascher, TC
Long-term treatment with nebivolol does not cause nitrate tolerance
J MOL CELL CARDIOL 2005 38: 1070-1070.
Web of Science
** Stoschitzky, G; Stoschitzky, K; Wascher, TC
Nicorandil does not cause nitrate tolerance when administered long-term
J MOL CELL CARDIOL 2005 38: 1070-1071.
Web of Science
** Stoschitzky, K; Stoschitzky, G
Nocturnal melatonin release is not affected by third generation beta-blockers
J MOL CELL CARDIOL 2005 38: 1071-1071.
Web of Science
** Stoschitzky, K; Stoschitzky, G
Clinically effective differences between beta-blocking effects of metoprolol, bisoprolol and carvedilol
J MOL CELL CARDIOL 2005 38: 1072-1072.
Web of Science
** Stoschitzky, K; Stoschitzky, G; Lamprecht, G; Lindner, W
Exercise does not affect plasma concentrations of third generation beta-blockers
J MOL CELL CARDIOL 2005 38: 1071-1072.
Web of Science
2004
Originalarbeit (Zeitschrift)
** Lamprecht, G; Stoschitzky, K
Determination of carvedilol in human plasma by high-performance liquid chromatography applying on-line deproteination and column switching
CHROMATOGRAPHIA 2004 59: 551-554.
Doi: 10.1365/s10337-004-0275-z
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Stoschitzky, G; Klein, W; Müller, F; Bühring, K; Lamprecht, G; Lindner, W
Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol.
Cardiovasc Drugs Ther. 2004; 18(2):135-138
Doi: 10.1023/B:CARD.0000029031.87129.05
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Sourij, H; Stoschitzky, K; Klein, W; Roth, M; Dittrich, P; Wascher, TC
Prevalence of undiagnosed pathological glucose metabolism in patients undergoing elective coronary angiography
DIABETOLOGIA 2004 47: A127-A127.
Web of Science
** Stoschitzky, G; Stoschitzky, K; Klein, W
Trough-to-peak-ratios of blood pressure lowering effects of bisoprolol, carvedilol and nebivolol
J HYPERTENSION 2004 22: S259-S260.
Doi: 10.1097/00004872-200406002-00912
Web of Science
FullText
FullText_MUG
** Stoschitzky, G; Stoschitzky, K; Wascher, TC; Klein, W
Long-term therapy with nebivolol does not cause nitrate tolerance
J HYPERTENSION 2004 22: S251-S251.
Doi: 10.1097/00004872-200406002-00881
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Stoschitzky, G; Klein, W
Differences between beta-blocking effects of metoprolol, bisoprolol and carvedilol
EUR HEART J 2004 25: 587-587.
Web of Science
** Stoschitzky, K; Stoschitzky, G; Klein, W
Lack of influence of third generation beta-blockers on nocturnal melatonin release
J HYPERTENSION 2004 22: S249-S250.
Doi: 10.1097/00004872-200406002-00875
Web of Science
FullText
FullText_MUG
2003
Abstract (Zeitschrift)
** Koshucharova, G; Stoschitzky, K; Klein, W
Long-term therapy with nebivolol does not cause nitrate tolerance.
CLIN PHARMACOL THER 2003 73: P92-P92.
Doi: 10.1016/S0009-9236(03)90695-3
Web of Science
FullText
FullText_MUG
** Koshucharova, G; Stoschitzky, K; Klein, W
Differences between beta-blocking effects of metoprolol, bisoprolol and carvedilol.
CLIN PHARMACOL THER 2003 73: P62-P62.
Doi: 10.1016/S0009-9236(03)90588-1
Web of Science
FullText
FullText_MUG
** Koshucharova, G; Stoschitzky, K; Klein, W
Long-term therapy with nebivolol does not cause nitrate tolerance
J AMER COLL CARDIOL 2003 41: 237A-237A.
Web of Science
** Koshucharova, G; Stoschitzky, K; Zweiker, R; Lercher, P; Maier, R; Watzinger, N; Klein, W
Different effects of propranolol, bisoprolol, carvedilol and doxazosin.
CLIN PHARMACOL THER 2003 73: P63-P63.
Doi: 10.1016/S0009-9236(03)90589-3
Web of Science
FullText
FullText_MUG
Kommentar
** Stoschitzky, K
The EUROPA trial.
Lancet. 2003; 362(9399):1935-1936
Doi: 10.1016%2FS0140-6736%2803%2914972-0
Web of Science
PubMed
FullText
FullText_MUG
2002
Originalarbeit (Zeitschrift)
** Lamprecht, G; Gruber, L; Stoschitzky, K; Lindner, W
Enantioselective analysis of (R)- and (S)-carvedilol in human plasma by high-performance liquid chromatography
CHROMATOGRAPHIA 2002 56: S35-S29.
Doi: 10.1007/BF02494109
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Koshucharova, G; Zweiker, R; Lercher, P; Maier, R; Klein, W; Zitta, S; Gruber, L; Lamprecht, G; Lindner, W
Exercise does not affect plasma concentrations of (R)- and (S)-carvedilol.
Cardiovasc Drugs Ther. 2002; 16(2):133-140
Doi: 10.1023%2FA%3A1015705516496
Web of Science
PubMed
FullText
FullText_MUG
** Stoschitzky, K; Zweiker, R; Klein, W; Zitta, S; Gruber, L; Lamprecht, G; Lindner, W
Unpredicted lack of effect of exercise on plasma concentrations of carvedilol.
J Cardiovasc Pharmacol. 2002; 39(1):58-60
Doi: 10.1097%2F00005344-200201000-00007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zweiker, R; Stoschitzky, K; Maier, R; Klein, W
Efficiency and safety of ACE-inhibiting imidapril in patients with essential hypertension
Acta Med Austriaca. 2002; 29(2):72-76
Doi: 10.1046%2Fj.1563-2571.2002.02007.x
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Stoschitzky, K
Beta-blockers in chronic heart failure.
Eur Heart J. 2002; 23(5):426; author reply 426-426; author reply 427
Doi: 10.1053/euhj.2001.3015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2001
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Koshucharova, G; Lercher, P; Maier, R; Sakotnik, A; Klein, W; Liebmann, PM; Lindner, W
Stereoselective effects of (R)- and (S)-carvedilol in humans.
Chirality. 2001; 13(7):342-346
Doi: 10.1002/chir.1042
Web of Science
PubMed
FullText
FullText_MUG
** Stoschitzky, K; Koshucharova, G; Zweiker, R; Maier, R; Watzinger, N; Fruhwald, FM; Klein, W
Differing beta-blocking effects of carvedilol and metoprolol.
Eur J Heart Fail. 2001; 3(3):343-349
Doi: 10.1016/S1388-9842(01)00126-X
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Koshucharova, G; Stoschitzky, K; Zweiker, R; Maier, R; Watzinger, N; Klein, W
Different beta-blocking effects of carvedilol and metoprolol.
CLIN PHARMACOL THER 2001 69: P34-P34.
Web of Science
** Stoschitzky, K; Koshucharova, G; Zweiker, R; Fruhwald, FM; Maier, R; Watzinger, N; Lercher, P; Klein, W
Different beta-blocking effects of metoprolol, bisoprolol and carvedilol in humans
EUR HEART J 2001 22: 299-299.
Doi: 10.1016%2FS1388-9842%2801%2900126-X
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Koshucharova, G; Zweiker, R; Maier, R; Lercher, P; Stepan, V; Klein, W
Comparing beta-blocking effects of carvedilol and bisoprolol in humans.
CLIN PHARMACOL THER 2001 69: P67-P67.
Web of Science
2000
Originalarbeit (Zeitschrift)
** Gasser, R; Koppel, H; Luha, O; Brussee, H; Stoschitzky, K; Tscheliessnigg, KH; Klein, W
Segmental degradation of left ventricular wall motion after persistent coronary fistula in a posttransplantation patient: a case report and short review of literature.
Transplantation. 2000; 69(10):2108-2111
Doi: 10.1097%2F00007890-200005270-00024
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Lamprecht, G; Kraushofer, T; Stoschitzky, K; Lindner, W
Enantioselective analysis of (R)- and (S)-atenolol in urine samples by a high-performance liquid chromatography column-switching setup.
J Chromatogr B Biomed Sci Appl. 2000; 740(2): 219-226.
Doi: 10.1016/S0378-4347(00)00080-3
Web of Science
PubMed
FullText
FullText_MUG
** Zitta, S; Stoschitzky, K; Zweiker, R; Lang, T; Holzer, H; Mayer, F; Reibnegger, G; Estelberger, W
Determination of renal reserve capacity by identification of kinetic systems
MATH COMPUT MODEL DYNAM SYST. 2000; 6: 190-207.
Doi: 10.1076/1387-3954(200006)6:2;1-M;FT190
Web of Science
FullText
FullText_MUG
Google Scholar
** Zitta, S; Stoschitzky, K; Zweiker, R; Oettl, K; Reibnegger, G; Holzer, H; Estelberger, W
Dynamic renal function testing by compartmental analysis: assessment of renal functional reserve in essential hypertension.
Nephrol Dial Transplant. 2000; 15(8):1162-1169
Doi: 10.1093/ndt/15.8.1162
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zweiker, R; Stoschitzky, K; Klein, W
Images in cardiology. Occlusion of the left main coronary artery without myocardial infarction.
Heart. 2000; 83(6):672-672
Doi: 10.1136/heart.83.6.672
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Stoschitzky, K; Lercher, P; Maier, R; Sakotnik, A
Chiral aspects of (R)- and (S)-carvedilol.
CLIN PHARMACOL THER 2000 67: 146-146.
Web of Science
** Zitta, S; Zweiker, R; Stoschitzky, K; Oettl, K; Reibnegger, G; Estelberger, W; Holzer, H
Effects of carvedilol and fosinopril on renal functional reserve and renal vascular resistance in essential hypertension
J HYPERTENSION 2000 18: S59-S59.
Doi: 10.1097/00004872-200006001-00198
Web of Science
FullText
FullText_MUG
1999
Originalarbeit (Zeitschrift)
** Sakotnik, A; Liebmann, PM; Stoschitzky, K; Lercher, P; Schauenstein, K; Klein, W; Eber, B
Decreased melatonin synthesis in patients with coronary artery disease.
Eur Heart J. 1999; 20(18):1314-1317
Doi: 10.1053/euhj.1999.1527
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stoschitzky, K; Sakotnik, A; Lercher, P; Zweiker, R; Maier, R; Liebmann, P; Lindner, W
Influence of beta-blockers on melatonin release.
Eur J Clin Pharmacol. 1999; 55(2):111-115
Doi: 10.1007%2Fs002280050604
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Stoschitzky, K
Trandolapril and human diabetic neuropathy.
Lancet. 1999; 353(9156):926-927
Doi: 10.1016/S0140-6736(05)75034-0
Web of Science
PubMed
FullText
FullText_MUG
1998
Originalarbeit (Zeitschrift)
** Watzinger, N; Brussee, H; Fruhwald, FM; Schumacher, M; Zweiker, R; Stoschitzky, K; Klein, W
Pericardiocentesis Guided by Contrast Echocardiography.
Echocardiography. 1998; 15(7):635-640
Doi: 10.1111/j.1540-8175.1998.tb00661.x
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Lercher, P; Stoschitzky, K; Sakotnik, A; Schumacher, M; Maier, R; Stoschitzky, P; Klein, W; Liebmann, P; Eber, B; Lindner, W
Betablockers and melatonin production
J AMER COLL CARDIOL 1998 31: 114A-114A.
Doi: 10.1016/S0735-1097(97)84201-5
Web of Science
FullText
FullText_MUG
** Stoschitzky, K; Oravcova, J; Stoschitzky, P; Maier, R; Schumacher, M; Dubovska, D; Klein, W; Lindner, W
Effects of intravenous (R)- and (S)-propranolol on plasma concentrations of (R)- and (S)-propranolol.
CLIN PHARMACOL THER 1998 63: 232-232.
Web of Science
** Stoschitzky, K; Sakotnik, A; Eber, B; Schumacher, M; Lercher, P; Maier, R; Stoschitzky, P; Liebmann, P; Lindner, W
Beta-blockers and melatonin.
CLIN PHARMACOL THER 1998 63: 137-137.
Web of Science
** Zitta, S; Holzer, H; Stoschitzky, K; Zweiker, R; Lang, T; Reibnegger, G; Estelbeger, W
Changes in dynamic renal function due to antihypertensive and antioxidative drugs.
CLIN PHARMACOL THER 1998 63: 237-237.
Web of Science
Kommentar
** Stoschitzky, K
Angiotensin II, VEGF, and diabetic retinopathy.
Lancet. 1998; 351(9105):836-837
Doi: 10.1016/S0140-6736(05)78972-8
Web of Science
PubMed
FullText
FullText_MUG
1997
Originalarbeit (Zeitschrift)
** Magometschnigg, D; Brandt, D; Hofmann, R; Sihorsch, K; Stoschitzky, K; Zangeneh, M; Zenker, G
Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
Int J Clin Pharmacol Ther. 1997; 35(9):389-396
Web of Science
PubMed
** Stoschitzky, K; Klein, W; Lindner, W
Time to reassess chiral aspects of beta-adrenoceptor antagonists.
Trends Pharmacol Sci. 1997; 18(9):306-307
Doi: 10.1016%2FS0165-6147%2897%2990649-0
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Stoschitzky, K; Klein, W
Beta blockers--1997 update
Wien Klin Wochenschr. 1997; 109(7):222-231
Web of Science
PubMed
Abstract (Zeitschrift)
** Stoschitzky, K; Lindner, W; Klein, W
The (R)- and (S)-enantiomers of beta-blockers are different drugs
J AMER COLL CARDIOL 1997 29: 27173-27173.
Web of Science
** Zitta, S; Stoschitzky, K; Zweiker, R; Lang, T; Reibnegger, G; Estelberger, W
Assessment of renal reserve capacity in hypertensives.
CLIN PHARMACOL THER 1997 61: PII89-PII89.
Web of Science
Kommentar
** Stoschitzky, K; Stark, G; Dacar, D
Massive pulmonary embolism.
N Engl J Med. 1997; 337(21):1561-1561
Doi: 10.1056%2FNEJM199711203372119
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1996
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Schumacher, M; Stark, G; Dimai, HP; Stauber, R; Stoschitzky, P; Krejs, GJ; Klein, W; Lindner, W
Exercise increases plasma concentrations of (R)- and (S)-propranolol.
Eur J Clin Pharmacol. 1996; 50(4):339-342
Doi: 10.1007/s002280050119
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Stoschitzky, K; Starz, I; Anelli-Monti, M; Rigler, B; Bauer, F; Klein, W
Transfusion-requiring haemolytic anaemia after mitral-valve repair.
Lancet. 1996; 347(9003):765-765
Doi: 10.1016/S0140-6736(96)90118-X
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Klein, W; Eber, B; Gasser, R; Stoschitzky, K; Schumacher, M; Fruhwald, FM; Zweiker, R
Current aspects of ACE inhibitor therapy from the cardiologic viewpoint
Wien Med Wochenschr. 1996; 146(11):221-224
PubMed
Abstract (Zeitschrift)
** Stoschitzky, K; Schumacher, M; Klein, W; Linder, W
Exercise and plasma concentrations of (R)- and (S)-propranolol during longterm treatment with (R,S)-propranolol.
CLIN PHARMACOL THER 1996 59: PII57-PII57.
Web of Science
Kommentar
** Stoschitzky, K
Hyperventilation syndrome.
Lancet. 1996; 348(9029):749-750
Doi: 10.1016/S0140-6736(05)65632-2
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
1995
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Kahr, S; Donnerer, J; Schumacher, M; Luha, O; Maier, R; Klein, W; Lindner, W
Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Clin Pharmacol Ther. 1995; 57(5):543-551
Doi: 10.1016/0009-9236(95)90039-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stoschitzky, K; Lindner, W; Kiowski, W
Stereoselective vascular effects of the (R)- and (S)-enantiomers of propranolol and atenolol.
J Cardiovasc Pharmacol. 1995; 25(2):268-272
Doi: 10.1097/00005344-199502000-00012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Klein, W; Eber, B; Dusleag, J; Gasser, R; Fruhwald, FM; Schumacher, M; Zweiker, R; Stoschitzky, K
Hypertension and hemorheology
Wien Med Wochenschr. 1995; 145(15-16):355-357
PubMed
** Zweiker, R; Eber, B; Schumacher, M; Stoschitzky, K; Pokan, R; Pieber, T; Klein, W
What are the therapeutic consequences of evaluating hypertensive patients with 24-hour blood pressure monitors and blood pressure self-measurement?
Wien Med Wochenschr. 1995; 145(15-16):365-372
PubMed
Abstract (Zeitschrift)
** STOSCHITZKY, K; EGGINGER, G; KLEIN, W; LINDNER, W
THE (R)-ENANTIOMERS AND (S)-ENANTIOMERS OF BETA-BLOCKERS ARE DIFFERENT DRUGS
CLIN PHARMACOL THER 1995 57: 194-194.
Web of Science
** STOSCHITZKY, K; KLEIN, W; LINDNER, W
EFFECTS OF EXERCISE ON PLASMA-CONCENTRATIONS OF (R)-ATENOLOL AND (S)-ATENOLOL
CLIN PHARMACOL THER 1995 57: 211-211.
Web of Science
1994
Originalarbeit (Zeitschrift)
** Egginger, G; Lindner, W; Brunner, G; Stoschitzky, K
Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
J Pharm Biomed Anal. 1994; 12(12):1537-1545
Doi: 10.1016%2F0731-7085%2894%2900129-4
Web of Science
PubMed
FullText
FullText_MUG
** Kiowski, W; Linder, L; Stoschitzky, K; Pfisterer, M; Burckhardt, D; Burkart, F; Bühler, FR
Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers.
Circulation. 1994; 90(1):27-34
Doi: 10.1161/01.CIR.90.1.27
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Stoschitzky, K; Lindner, W; Klein, W
Chiral aspects of beta-adrenoceptor antagonists.
Trends Pharmacol Sci. 1994; 15(4):102-102
Doi: 10.1016/0165-6147(94)90044-2
Web of Science
PubMed
FullText
FullText_MUG
1993
Originalarbeit (Zeitschrift)
** Egginger, G; Lindner, W; Kahr, S; Stoschitzky, K
Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
Chirality. 1993; 5(7):505-512
Doi: 10.1002/chir.530050706
Web of Science
PubMed
FullText
FullText_MUG
** Stoschitzky, K; Egginger, G; Zernig, G; Klein, W; Lindner, W
Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
Chirality. 1993; 5(1):15-19
Doi: 10.1002/chir.530050104
Web of Science
PubMed
FullText
FullText_MUG
1992
Originalarbeit (Zeitschrift)
** Stark, U; Stark, G; Stoschitzky, K; Pilger, E; Nagl, S; Lindner, W; Tritthart, HA
Stereoselective electrophysiological effects of propafenone in Langendorff perfused guinea pig hearts.
Basic Res Cardiol. 1992; 87(1):87-97
Doi: 10.1007/BF00795393
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stoschitzky, K; Lindner, W; Egginger, G; Brunner, F; Obermayer-Pietsch, B; Passath, A; Klein, W
Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
Clin Pharmacol Ther. 1992; 51(4): 445-453.
Doi: 10.1038/clpt.1992.45
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stoschitzky, K; Lindner, W; Klein, W
Stereoselective release of (S)-atenolol from adrenergic nerve endings at exercise.
Lancet. 1992; 340(8821):696-697
Doi: 10.1016/0140-6736(92)92233-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1990
Originalarbeit (Zeitschrift)
** Stoschitzky, K; Klein, W; Stark, G; Stark, U; Zernig, G; Graziadei, I; Lindner, W
Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
Clin Pharmacol Ther. 1990; 47(6):740-746
Doi: 10.1038/clpt.1990.102
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Übersichtsarbeit
** Stoschitzky, K; Lindner, W
Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol
Wien Med Wochenschr. 1990; 140(6-7):156-162
Web of Science
PubMed
Google Scholar
1989
Originalarbeit (Zeitschrift)
** Lindner, W; Rath, M; Stoschitzky, K; Semmelrock, HJ
Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
Chirality. 1989; 1(1):10-13
Doi: 10.1002/chir.530010105
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lindner, W; Rath, M; Stoschitzky, K; Uray, G
Enantioselective drug monitoring of (R)- and (S)- propranolol in human plasma via derivatization with optically active (R,R)-O,O-diacetyl tartaric acid anhydride.
J Chromatogr. 1989; 487(2):375-383
Doi: 10.1016/S0378-4347(00)83045-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stoschitzky, K; Lindner, W; Rath, M; Leitner, C; Uray, G; Zernig, G; Moshammer, T; Klein, W
Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.
Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(4):474-478
Doi: 10.1007/BF00736064
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar